Sphygmomanometer

LiveCare Inc's (OTCMKTS: LVCE) Blood Pressure Cuff Sets New Standards in Healthcare, Fueling Remarkable Growth and Patient Adoption

Retrieved on: 
Tuesday, March 5, 2024

The introduction of the Blood Pressure Cuff by LiveCare Inc has opened a vast new market, catering to the needs of more than 122 million people with high blood pressure, according to a 2023 report from the American Heart Association.

Key Points: 
  • The introduction of the Blood Pressure Cuff by LiveCare Inc has opened a vast new market, catering to the needs of more than 122 million people with high blood pressure, according to a 2023 report from the American Heart Association.
  • Recognizing the challenges and discomfort associated with traditional blood glucose monitoring methods, LiveCare Inc has ingeniously addressed a critical healthcare gap.
  • “The success of our Blood Pressure Cuff is a testament to our commitment to our patients.
  • The success of the Blood Pressure Cuff is a testament to LiveCare Inc's commitment to advancing healthcare through technology connected to its Health Center supporting 24/7 live human interaction.

Hanvon Technology Launches Groundbreaking Fourth-Generation BP Meter Based on Korotkoff Sound Method

Retrieved on: 
Thursday, February 29, 2024

BEIJING, Feb. 28, 2024 /PRNewswire/ -- Hanvon Technology Co., Ltd., based in China, has launched the world's first smart electronic BP Meter utilizing the Korotkoff sound method. This device integrates advanced sensor technology with artificial intelligence algorithms, overcomes the accuracy limitations of traditional electronic BP Meter, and achieves the precision of mercury sphygmomanometers; it starts a new era of Electronic BP Meters.

Key Points: 
  • BEIJING, Feb. 28, 2024 /PRNewswire/ -- Hanvon Technology Co., Ltd., based in China, has launched the world's first smart electronic BP Meter utilizing the Korotkoff sound method.
  • This device integrates advanced sensor technology with artificial intelligence algorithms, overcomes the accuracy limitations of traditional electronic BP Meter, and achieves the precision of mercury sphygmomanometers; it starts a new era of Electronic BP Meters.
  • The Korotkoff sound method, developed by Russian physician Nikolai Korotkoff in 1905.
  • Hanvon BP Meter with Korotkoff sound method is now available in China mainland, and is expected to enter the international market in the near future.

Global Blood Pressure Monitors Market Research Report 2023: A $3.1 Billion Market by 2031 - North America Dominates but Asia-Pacific Shows Rapid Growth

Retrieved on: 
Tuesday, October 3, 2023

DUBLIN, Oct. 3, 2023 /PRNewswire/ -- The "Global Blood Pressure Monitors Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Oct. 3, 2023 /PRNewswire/ -- The "Global Blood Pressure Monitors Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.
  • The global blood pressure monitors market size attained a value of USD 1.67 billion in 2022.
  • The uses of blood pressure monitors are multifaceted, including the management of hypertension (high blood pressure) in individuals, ensuring the effectiveness of treatment regimens.
  • In summary, blood pressure monitors are essential tools in healthcare for measuring blood pressure, managing hypertension, and assessing overall cardiovascular risk.

Global Blood Pressure Monitors Pipeline Report 2022: Featuring Aktiia, AtCor Medical, Barron Associates and Blumio Among Others - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 13, 2022

The "Blood Pressure Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Blood Pressure Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.
  • This report provides comprehensive information about the Blood Pressure Monitors pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
  • Blood Pressure Monitors includes blood pressure transducers that convert blood pressure into electrical signals and sphygmomanometers, a device consisting of a pressure gauge and a rubber cuff that wraps around the upper arm and wrist which inflates to constrict the arteries and measure the blood pressure.
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
    The report enables you to:
    In-depth analysis of the product's current stage of development, territory and estimated launch date

Smart Wearable Healthcare Devices Market size worth $ 37.4 Billion, Globally, by 2028 at 13.1% CAGR: Verified Market Research®

Retrieved on: 
Tuesday, April 19, 2022

JERSEY CITY, N.J., April 19, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Smart Wearable Healthcare Devices Market" By Product (Blood Glucose Meter, Blood Pressure Monitor, Heart Detector), By End-User (Children, Adults, The Old Aged), and By Geography. According to Verified Market Research, the Global Smart Wearable Healthcare Devices Market size was valued at USD 13.8 Billion in 2020 and is projected to reach USD 37.4 Billion by 2028, growing at a CAGR of 13.1% from 2021 to 2028.

Key Points: 
  • Growing demand for Wearable Healthcare Devices during COVID-19 pandemic, increasing personal health monitoring, healthy life style orientation, fitness awareness and other factors are to lead Smart Wearable Healthcare Devices Market growth.
  • According to Verified Market Research, the Global Smart Wearable Healthcare Devices Market size was valued at USD 13.8 Billion in 2020 and is projected to reach USD 37.4 Billion by 2028, growing at a CAGR of 13.1% from 2021 to 2028.
  • During the pandemic, the market for Smart wearable Healthcare Devices has seen a moderately beneficial influence.
  • Verified Market Research has segmented the Global Smart Wearable Healthcare Devices Market On the basis of Product, End-User, and Geography.

Smart Wearable Healthcare Devices Market size worth $ 37.4 Billion, Globally, by 2028 at 13.1% CAGR: Verified Market Research®

Retrieved on: 
Tuesday, April 19, 2022

JERSEY CITY, N.J., April 19, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Smart Wearable Healthcare Devices Market" By Product (Blood Glucose Meter, Blood Pressure Monitor, Heart Detector), By End-User (Children, Adults, The Old Aged), and By Geography. According to Verified Market Research, the Global Smart Wearable Healthcare Devices Market size was valued at USD 13.8 Billion in 2020 and is projected to reach USD 37.4 Billion by 2028, growing at a CAGR of 13.1% from 2021 to 2028.

Key Points: 
  • Growing demand for Wearable Healthcare Devices during COVID-19 pandemic, increasing personal health monitoring, healthy life style orientation, fitness awareness and other factors are to lead Smart Wearable Healthcare Devices Market growth.
  • According to Verified Market Research, the Global Smart Wearable Healthcare Devices Market size was valued at USD 13.8 Billion in 2020 and is projected to reach USD 37.4 Billion by 2028, growing at a CAGR of 13.1% from 2021 to 2028.
  • During the pandemic, the market for Smart wearable Healthcare Devices has seen a moderately beneficial influence.
  • Verified Market Research has segmented the Global Smart Wearable Healthcare Devices Market On the basis of Product, End-User, and Geography.

Blood Pressure Monitors Medical Devices Pipeline Product Landscape - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 16, 2022

The "Blood Pressure Monitors (Healthcare IT) - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Blood Pressure Monitors (Healthcare IT) - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.
  • The report provides comprehensive information about the Blood Pressure Monitors pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
  • This category includes blood pressure transducers that convert blood pressure into electrical signals and sphygmomanometers, a device consisting of a pressure gauge and a rubber cuff that wraps around the upper arm and wrist which inflates to constrict the arteries and measure the blood pressure.
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
    In-depth analysis of the product's current stage of development, territory and estimated launch date

World's first automated 24/7 blood pressure monitor comes to the USA

Retrieved on: 
Tuesday, January 4, 2022

In the United States, nearly 50% of adults, about 116 million people, have high blood pressure.

Key Points: 
  • In the United States, nearly 50% of adults, about 116 million people, have high blood pressure.
  • Yet current measurement devices only capture a brief snapshot of overall blood pressure, and they are burdensome to use.
  • Aktiia'sOptical Blood Pressure Monitoring (OBPM) algorithms leverage optical sensors worn on the wrist and provide blood pressure values using photoplethysmography (PPG) toanalyzethe changing diameter of the arteries occurring at each heartbeat.
  • Founded in Switzerland in May 2018, Aktiia'steam has some of the world's leading scientific and technical experts in optical blood pressure monitoring.

Biobeat Launches Wearable Continuous Ambulatory Blood Pressure Monitoring (ABPM) Device

Retrieved on: 
Wednesday, May 26, 2021

PETAH TIKVA, Israel, May 26, 2021 /PRNewswire/ -- Biobeat , a global leader in wearable remote patient monitoring solutions for the healthcare continuum, announced today the launch of its new wearable and continuous ambulatory blood pressure monitoring (ABPM) chest-monitoring device.

Key Points: 
  • PETAH TIKVA, Israel, May 26, 2021 /PRNewswire/ -- Biobeat , a global leader in wearable remote patient monitoring solutions for the healthcare continuum, announced today the launch of its new wearable and continuous ambulatory blood pressure monitoring (ABPM) chest-monitoring device.
  • "Biobeat is excited to support this positive trend with our new wearable ABPM solution, giving providers a continuous and accurate real-life view into patient cardiac health, replacing antiquated cuff-based technology."
  • The study, which compared Biobeat's wearable wrist-monitoring device to a standard cuff-based ABPM device, found that Biobeat's device has ABPM monitoring capabilities comparable to the standard cuff-based ABPM device.
  • Biobeat's wearable devices are the first devices to be FDA-Cleared for cuffless non-invasive PPG-based blood pressure monitoring and are also fully CE Mark certified.

Biospectal Announces Two Independent Global Health Research and Validation Studies Using Biospectal OptiBP™ Blood Pressure Measurement App

Retrieved on: 
Thursday, May 20, 2021

The two new independent global health research and validation studies follow the recent publication of a large-scale, third-party research study in Scientific Reports in Nature , which demonstrated Biospectal\'s ability to measure blood pressure as accurately as a sphygmomanometer, commonly referred to as a standard blood pressure cuff.

Key Points: 
  • The two new independent global health research and validation studies follow the recent publication of a large-scale, third-party research study in Scientific Reports in Nature , which demonstrated Biospectal\'s ability to measure blood pressure as accurately as a sphygmomanometer, commonly referred to as a standard blood pressure cuff.
  • The OptiBP medical-grade smartphone app uses a smartphone camera\'s lens to easily measure and record a user\'s blood pressure flow via their fingertip.
  • Using proprietary algorithms and optical signal capture methods, Biospectal OptiBP then transforms the captured data into blood pressure values in approximately 20 seconds half the time of a typical blood pressure cuff.
  • "We can scale our modern, medical-grade,easy-to-use blood pressure measurement and monitoring OptiBP technologyglobally with extreme efficiency to any country, at any time.